Powered by: Motilal Oswal
2026-06-11 02:01:06 pm | Source: Emkay Global Financial Services Ltd
Buy Honasa Consumer Ltd for the Target Rs 500 by Emkay Global Financial Services Ltd
Buy Honasa Consumer Ltd for the Target Rs 500 by Emkay Global Financial Services Ltd

We attended Honasa’s ‘Investor Day’ on 10-Jun-26 where the company shared its vision for FY31. Honasa aims to become the fastest-growing domestic FMCG player and reach >Rs50bn in revenue, with significant expansion of 500bps in EBITDA margin to 15% by FY31. This is likely to be achieved via improved innovation accuracy (trend mapping, additive partition-based innovation, investment mix change), product superiority, personalized and user generated content-led communication, and leveraging AI for superior execution, per the management. The mgmt discussed the rationale for change in its offline strategy in 2024 with great transparency and seemed much more confident of the current strategy. Our estimates are unchanged; retain BUY and TP of Rs500.

Target for FY31

The management aims to reach revenue of over Rs55bn (from ~Rs24bn in FY26), implying a CAGR of 18%. Mamaearth and The Derma Co (TDC) are expected to contribute Rs37.5bn to revenue, with the balance expected from other brands (Rs15bn) and Rs2.5bn from next-horizon categories (nutraceuticals, fragrances, oral care). The management aims to scale-up Mamaearth into a >Rs20bn brand and The Derma Co into a >Rs15bn brand, while building at least two additional brands, with revenue exceeding Rs5bn each. On the margin front, the management expects EBITDA margin to expand from ~10% in FY26 to >15% by FY31, driven by an improved channel mix (100-150bps), channel-spend efficiencies (100-150bps), operating leverage (150-200bps), and favorable category mix (100-150bps).

Other KTAs

The management highlighted that the company was built on a repeatable playbook comprising consumer-first innovation, digital-first communication, digital-first channel leadership, data-driven decision making, and consumer-obsessed talent. The success of Mamaearth enabled the creation of multiple brands, including The Derma Co, Aqualogica, Dr Sheth's, Staze, and BBlunt, reinforcing the management's belief that its competitive advantage lies in identifying emerging consumer needs and building India-specific propositions rather than relying on any single brand. Honasa sees a significant runway ahead, with >50% of revenue currently generated from only eight dominant category partitions while more than 80 partitions remain untapped. Looking ahead, Honasa 2.0 will focus on AI-enabled innovation, superior product formulations, personalized consumer engagement, and technology-led execution, supported by investments in R&D, proprietary AI workflows, and omnichannel distribution. The management also highlighted the success of Project Neev, which strengthened GT execution through sharper assortment planning, enhanced technology infrastructure, and improved distributor productivity, resulting in direct distribution reach expanding to ~120k outlets now, with ambition to reach a >300k outlet-count by FY31.

 

 

For More  Emkay Global Financial Services Ltd Disclaimer http://www.emkayglobal.com/Uploads/disclaimer.pdf & SEBI Registration number is INH000000354

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here